Osteopontin gene and stroke risk in Egypt
Part of Brain & nervous system, Heart & circulation clinical trials.
This study looks at how a gene called Osteopontin might affect stroke in people from Egypt. Researchers will compare stroke patients with healthy volunteers to see if certain gene variations are linked to stroke risk or recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old (for stroke patients) or over 18 (if you are a healthy volunteer).
- You have had a stroke with symptoms that started within the last 24 hours, or you had a stroke 3 to 6 months ago.
- If you are a healthy volunteer, you have no history of stroke or other major health problems.
- You do not have heart disease, heart failure, chronic inflammation, a brain tumor, or a bleeding disorder.
- You do not have severe liver or kidney problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how common large blood vessel blockages are in people who have had a stroke. It helps doctors understand more about stroke causes and may lead to better treatment options.
This study looks at how certain proteins in the blood change after a procedure to remove a large blockage in a brain artery. The goal is to better understand recovery after stroke treatment.
This trial tests whether using a rapid genetic test to choose antiplatelet medication can improve outcomes for people who have had a stroke or mini-stroke. The test checks a gene that affects how your body processes a common antiplatelet drug, so your doctors can pick the safest and most effective medicine for you.
This study looks at how quickly brain damage from a stroke progresses in Afro-Caribbean people. If you are in the hospital for a severe stroke and you meet the criteria, researchers will monitor your condition to understand more about the disease.
This trial tests whether giving a clot-busting medicine (alteplase) through a video-guided emergency call (telemedicine) is safe and effective for patients in Oman who have had a stroke within the last 4.5 hours.
This study looks for biological and imaging markers that may predict heart/vascular outcomes after an ischemic stroke. You may join if you are eligible for standard stroke treatment and can complete planned follow-up and MRI scans.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.